NDC 0093-3107-19 - Amoxicillin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0093-3107
- Requested NDC
- 0093-3107-19
- Package NDCs from labels
- 0093-3107-01, 0093-3107-05, 0093-3107-19
- Manufacturer
- Northwind Health Company, LLC
- Effective date
- 2026-09-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Amoxicillin - Northwind Health Company, LLC | Northwind Health Company, LLC | 2026-09-15 | HUMAN PRESCRIPTION DRUG LABEL |
| Amoxicillin - Teva Pharmaceuticals USA, Inc. | Teva Pharmaceuticals USA, Inc. | 2025-09-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Amoxicillin - Redpharm Drug | Redpharm Drug | 2025-08-23 | HUMAN PRESCRIPTION DRUG LABEL |
| Amoxicillin - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2025-02-06 | HUMAN PRESCRIPTION DRUG LABEL |
| Amoxicillin - PD-Rx Pharmaceuticals, Inc. | PD-Rx Pharmaceuticals, Inc. | 2025-01-02 | HUMAN PRESCRIPTION DRUG LABEL |
| Amoxicillin - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2024-06-18 | HUMAN PRESCRIPTION DRUG LABEL |
| Amoxicillin - RedPharm Drug Inc. | TEVA Pharmaceuticals USA Inc | RedPharm Drug Inc. | TEVA Pharmaceuticals USA Inc | 2011-07-01 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0093-3107-01 | Amoxicillin | 100 in 1 BOTTLE | CAPSULE | 100 | 37 | |
| 0093-3107-05 | Amoxicillin | 500 in 1 BOTTLE | CAPSULE | 500 | 37 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0093-3107 | AMOXICILLIN TABLET, FILM COATED AMOXICILLIN POWDER, FOR SUSPENSION AMOXICILLIN TABLET, CHEWABLE AMOXICILLIN CAPSULE [TEVA PHARMACEUTICALS USA, INC.] | 34 | Current NDC, Legacy NDC, 2 package rows | 20250502_4c0f348a-a65d-409c-8668-207c82a5e3cb.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0093-3107-01 | EA - Each | 0093-3107 | 6ea822c0-56a6-4f83-b717-86bf50d9e152 | 1 | 2012-07-24 |
| 0093-3107-05 | EA - Each | 0093-3107 | b43ad8f8-514c-4809-ba95-94ff20b028f4 | 1 | 2012-07-24 |
| 0093-3107-19 | EA - Each | 0093-3107 | c8271ba2-2c04-4e56-bbfb-2c486f63eec0 | 1 | 2012-07-24 |
| 0093-3107-93 | EA - Each | 0093-3107 | 625290d0-9958-4b8b-b976-bbd625c4515c | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amoxicillin | AMOXICILLIN | PD-Rx Pharmaceuticals, Inc. | d37f2e3c-01f0-4a81-a46f-1615b82e2499 | 2026-11-09 | Warnings, Adverse reactions | 804826J2HU |
| AMOXICILLIN | AMOXICILLIN | Redpharm Drug | 5f988a71-c189-7200-e063-6294a90a0f37 | 2026-11-06 | Warnings, Adverse reactions | 804826J2HU |
| BEVERHILL HAIR TONIC | UNDARIA PINNATIFIDA EXTRACT, CAMELLIA SINENSIS LEAF EXTRACT, MORUS ALBA BARK EXTRACT, PINUS DENSIFLORA LEAF EXTRACT, ARTEMISIA VULGARIS EXTRACT, SESAMUM INDICUM SEED EXTRACT, SODIUM BENZOATE | BIOHERB Co., Ltd. | 32733977-606e-f110-e063-6294a90aba8f | 2026-11-06 | Warnings | OJ245FE5EU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | PD-Rx Pharmaceuticals, Inc. | b04330a0-2b8d-4cf9-a08e-19007d1001ad | 2026-11-05 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | PD-Rx Pharmaceuticals, Inc. | 09660a95-a7b3-4d1f-832c-a4fa7a5b7ddd | 2026-11-05 | Warnings, Adverse reactions | ANDA064013 598025 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | PD-Rx Pharmaceuticals, Inc. | 416fa58c-88fa-42aa-9195-74aeba641577 | 2026-11-05 | Warnings, Adverse reactions | 804826J2HU |
| Eyewash Station Additive Concentrate | CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL | Encon Safety Products, Inc. | b5a62567-c9f1-0492-e053-2a95a90ab247 | 2026-11-05 | Warnings | 6DC9Q167V3 |
| COOLA 70 PERCENT PLUS ORGANIC MINERAL BODY SUNSCREEN SPF50 | TITANIUM DIOXIDE, ZINC OXIDE | COOLA, LLC | cb95c712-1680-4040-e053-2995a90af004 | 2026-11-04 | Warnings | 15FIX9V2JP |
| Vertra Ehukai Beige Sunscreen Face Stick Broad Spectrum SPF 38 | TITANIUM DIOXIDE | Eai-jr 286, Inc | 303d5d5a-4c7a-1e23-e063-6294a90a0e58 | 2026-11-04 | Warnings | 15FIX9V2JP |
| Vertra Mick Fanning Signature Foundation Sunscreen Face Stick SPF 35 Coolangatta Beige | TITANIUM DIOXIDE | EAI-JR 286, Inc. | b9ea12e8-6ed9-d805-e053-2a95a90aa107 | 2026-11-04 | Warnings | 15FIX9V2JP |
| Vertra Pearl White Face Stick SPF 50 | PADIMATE O, TITANIUM DIOXIDE | Eai-jr 286, Inc | b69a75e0-8724-35ae-e053-2a95a90a5f34 | 2026-11-04 | Warnings | 15FIX9V2JP |
| Vertra S Dorian Kona Gold Signature Face Stick SPF 38 | TITANIUM DIOXIDE | Eai-jr 286, Inc | b6c316c3-661b-6428-e053-2a95a90a1a6b | 2026-11-04 | Warnings | 15FIX9V2JP |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | PD-Rx Pharmaceuticals, Inc. | 0425932a-f6e1-49a6-8480-720f179ace14 | 2026-11-03 | Warnings, Adverse reactions | 804826J2HU |
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2026-11-02 | Warnings, Adverse reactions | 3OWL53L36A |
| HERA SILKYSTAY FOUNDATION 34W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f3ef340-c68e-1790-e063-6394a90a44aa | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 35C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f40c97f-b90e-bec7-e063-6394a90ae5db | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 35N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f40f46b-c6b2-df1f-e063-6394a90afd96 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 37W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4105f3-d08b-edb5-e063-6394a90ad28b | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 39N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f41120a-521a-f5ac-e063-6394a90ac021 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 41W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4158f0-c743-29c2-e063-6394a90ac721 | 2026-11-01 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.